ArticleInternational journal of hypertension2013

Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study.

Irina Chazova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.